These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11906071)

  • 1. Inactivation of Cryptosporidium parvum oocysts by bacterial strains.
    Deng M; Nuanualsuwan S; Cliver DO
    J Eukaryot Microbiol; 2001; Suppl():37S-39S. PubMed ID: 11906071
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of sodium hypochlorite exposure on infectivity of Cryptosporidium parvum oocysts for neonatal BALB/c mice.
    Fayer R
    Appl Environ Microbiol; 1995 Feb; 61(2):844-6. PubMed ID: 7574626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of common laboratory disinfectants on the infectivity of Cryptosporidium parvum oocysts in cell culture.
    Weir SC; Pokorny NJ; Carreno RA; Trevors JT; Lee H
    Appl Environ Microbiol; 2002 May; 68(5):2576-9. PubMed ID: 11976138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete development of Cryptosporidium parvum in MDBK cells.
    Villacorta I; de Graaf D; Charlier G; Peeters JE
    FEMS Microbiol Lett; 1996 Aug; 142(1):129-32. PubMed ID: 8759799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of Cryptosporidium parvum under laboratory conditions.
    Delling C; Holzhausen I; Daugschies A; Lendner M
    Parasitol Res; 2016 Feb; 115(2):863-6. PubMed ID: 26566617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of cell culture and quantitative PCR (cc-qPCR) to assess disinfectants efficacy on Cryptosporidium oocysts under standardized conditions.
    Shahiduzzaman M; Dyachenko V; Keidel J; Schmäschke R; Daugschies A
    Vet Parasitol; 2010 Jan; 167(1):43-9. PubMed ID: 19850414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of three common hospital liquid germicides to inactivate Cryptosporidium parvum oocysts.
    Wilson JA; Margolin AB
    J Hosp Infect; 1999 Jul; 42(3):231-7. PubMed ID: 10439996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utilization of sodium taurocholate in excystation of Cryptosporidium parvum and infection of tissue culture.
    Gold D; Stein B; Tzipori S
    J Parasitol; 2001 Oct; 87(5):997-1000. PubMed ID: 11695421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Cryptosporidium parvum development in various cell lines for screening in vitro drug testing.
    Siripanth C; Punpoowong B; Amarapal P; Thima N; Eampokalap B; Kaewkungwal J
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):540-6. PubMed ID: 15689063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of viability and infectivity of waterborne Cryptosporidium parvum oocysts.
    Uguen C; Brasseur P; Moreno-Sabater A; Favennec L; Ballet JJ
    J Eukaryot Microbiol; 1997; 44(6):73S. PubMed ID: 9508453
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of two commercial disinfectants on the viability and infectivity of Cryptosporidium parvum oocysts.
    Castro-Hermida JA; Pors I; Méndez-Hermida F; Ares-Mazás E; Chartier C
    Vet J; 2006 Mar; 171(2):340-5. PubMed ID: 16490718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistical comparison of excystation methods in Cryptosporidium parvum oocysts.
    Pecková R; Stuart PD; Sak B; Květoňová D; Kváč M; Foitová I
    Vet Parasitol; 2016 Oct; 230():1-5. PubMed ID: 27884435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of the mixed-oxidant solution on infectivity of Cryptosporidium parvum oocysts in a neonatal mouse model].
    Sasahara T; Aoki M; Sekiguchi T; Takahashi A; Satoh Y; Kitasato H; Inoue M
    Kansenshogaku Zasshi; 2003 Feb; 77(2):75-82. PubMed ID: 12661082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of activity of an association of detergent and germicidal agents on the infectivity of Cryptosporidium parvum oocysts.
    Vassal S; Favennec L; Ballet JJ; Brasseur P
    J Infect; 1998 Mar; 36(2):245-7. PubMed ID: 9570672
    [No Abstract]   [Full Text] [Related]  

  • 15. Cryptosporidium parvum: treatment effects and the rate of decline in oocyst infectivity.
    Coulliette AD; Huffman DE; Slifko TR; Rose JB
    J Parasitol; 2006 Feb; 92(1):58-62. PubMed ID: 16629316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of bovine manure on Cryptosporidium parvum oocyst attachment to soil.
    Kuczynska E; Shelton DR; Pachepsky Y
    Appl Environ Microbiol; 2005 Oct; 71(10):6394-7. PubMed ID: 16204565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infectivity of preserved Cryptosporidium parvum oocysts for immunosuppressed adult mice.
    Yang S; Healey MC; Du C
    FEMS Immunol Med Microbiol; 1996 Feb; 13(2):141-5. PubMed ID: 8731022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of Cryptosporidium parvum oocysts in field soil.
    Kato S; Jenkins MB; Ghiorse WC; Fogarty EA; Bowman DD
    Southeast Asian J Trop Med Public Health; 2001; 32 Suppl 2():183-9. PubMed ID: 12041587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Labeling surface epitopes to identify Cryptosporidium life stages using a scanning electron microscopy-based immunogold approach.
    Edwards H; Thompson RC; Koh WH; Clode PL
    Mol Cell Probes; 2012 Feb; 26(1):21-8. PubMed ID: 22100878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A non-biological surrogate for sequential disinfection processes.
    Baeza C; Ducoste J
    Water Res; 2004; 38(14-15):3400-10. PubMed ID: 15276757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.